Lorlatinib Salvages CNS Relapse in an ALK-Positive...

Clinical Lung Cancer 2018 / 11

Lorlatinib Salvages CNS Relapse in an ALK-Positive Non–Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib

Sakamoto, Mandy R., Honce, Justin M., Lindquist, Deborah L., Camidge, D. Ross
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2018.11.010
Date:
November, 2018
File:
PDF, 577 KB
english, 2018
Conversion to is in progress
Conversion to is failed